Walgreens Boots Alliance (WBA) has completed the sale of its wholesaler arm, Alliance Healthcare, to US wholesale company AmerisourceBergen Corporation for $6.5bn.
The sale, first announced in January, was finalised for $6.275bn cash and two million shares of AmerisourceBergen common stock, WBA announced yesterday (2 June).
Related Article: What will hub and spoke changes mean for independents?
The company said it would use cash proceeds from the sale to ‘reduce debt and accelerate growth of its core retail pharmacy and healthcare businesses’.
WBA previously confirmed that Alliance Healthcare UK will remain the distribution partner of Boots UK until 2031, as part of the deal.
Related Article: NICE approves once-a-day pill linzagolix for endometriosis
Rosalind Brewer, chief executive of Walgreens Boots Alliance, said: ‘Completion of this transaction represents a significant step forward in our transformation and will fuel investments to grow WBA’s core retail pharmacy and healthcare businesses.
‘Through these and other investments, WBA looks to bring even more innovative healthcare offerings to our customers and patients, as we further accelerate our strategic priorities.’
Steven Collis, chairman, president and chief executive officer of AmerisourceBergen, said the acquisition of Alliance Healthcare ‘expands our reach and solutions in pharmaceutical distribution and adds to AmerisourceBergen’s breadth and depth of global manufacturer services’.
Related Article: Thinktank recommends 'fluid' supervision throughout ARRS career
He added: ‘With Alliance Healthcare, we will advance our ability to provide innovative and global healthcare solutions and further our purpose of being united in our responsibility to create healthier futures.’
Have your say
Please add your comment in the box below. You can include links, but HTML is not permitted. Please note that comments are not moderated before publication and the views expressed are those of the user and do not reflect the views of The Pharmacist. Remember that submission of comments is governed by our Terms and Conditions. You can also read our full guidelines on article comments here – but please be aware that you are legally liable for any libellous or offensive comments that you make. If you have a complaint about a comment or are concerned that a comment breaches our terms and conditions, please use the ‘Report this comment’ function to alert our web team.